A report from Romanian TV, one year on from the European Parliament cash-for-influence scandal, in English and Romanian.
One year on from cash-for-influence
New rules needed to curb power of corporate lobbyists in the European Parliament
28 March 2012 - New research reveals that the pharmaceutical industry lobby is spending more than €40 million annually to influence decision making in the European Union (EU) – of which nearly half is spent by drug manufacturers on in-house lobbyists.
According to these findings, civil society organisations active on EU medicines issues, on the other hand, spend a combined €3.4 million per year. With the immense disparity between the affluence of public interest groups and the industrial lobby, it becomes even more difficult to level the policy playing field.
Corporate Europe Observatory
Corporate Europe Observatory (CEO) is a research and campaign group working to expose and challenge the privileged access and influence enjoyed by corporations and their lobby groups in EU policy making.